Table 2 Number and percentage of participants with each health condition at baseline, 12-month, and 24-month follow-ups
|  | Baseline (N = 954) | 12-month follow-up (N = 767) | 24-month follow-up (N = 568) |
|---|---|---|---|
Health conditions | Â | Â | Â |
Yes, N (%) | |||
Myocardial infarction (history of heart attacks) | 53 (5.6) | 53 (6.9) | 44 (7.7) |
Congestive heart failure | 10 (1.0) | 15 (2.0) | 20 (3.5) |
Hypertension/high blood pressure | 359 (37.6) | 349 (45.5) | 274 (48.2) |
Diagnosed depression | 77 (8.1) | 81 (10.6) | 67 (11.8) |
Peripheral vascular disease | 47 (4.9) | 66 (8.6) | 56 (9.9) |
 Aortic aneurysm | 7 (0.7) | 10 (1.3) | 9 (1.6) |
 Poor circulation | 27 (2.8) | 40 (5.2) | 34 (6.0) |
Cerebrovascular disease | 50 (5.2) | 55 (7.2) | 43 (7.6) |
 Stroke | 18 (1.9) | 25 (3.3) | 20 (3.5) |
 Cerebrovascular accident | 1 (0.1) | 0 (0) | 2 (0.4) |
 Transient Ischemic attack | 25 (2.6) | 30 (3.9) | 24 (4.2) |
Dementia | 49 (5.1) | 44 (5.7) | 30 (5.3) |
Chronic bad chest | 103 (10.8) | 115 (15.0) | 100 (17.6) |
 Asthma | 65 (6.8) | 74 (9.6) | 67 (11.8) |
 Chronic obstructive pulmonary disease | 28 (2.9) | 35 (4.6) | 34 (6.0) |
 Chronic bronchitis | 8 (0.8) | 8 (1.0) | 7 (1.2) |
Emphysema | 4 (0.4) | 8 (1.0) | 7 (1.2) |
Inflammation affecting the joints | 246 (25.8) | 276 (36.0) | 230 (40.5) |
 Lupus | 3 (0.3) | 1 (0.1) | 1 (0.2) |
 Rheumatoid arthritis | 91 (9.5) | 119 (15.5) | 106 (18.7) |
 Connective tissue disease | 5 (0.5) | 5 (0.7) | 6 (1.1) |
 Vasculitis | 3 (0.3) | 2 (0.3) | 2 (0.4) |
Peptic/stomach ulcer disease | 27 (2.8) | 29 (3.8) | 25 (4.4) |
Skin ulcer | 9 (0.9) | 11 (1.4) | 11 (1.9) |
 Bed sores | 0 (0) | 0 (0) | 0 (0) |
 Repeated cellulitis | 7 (0.7) | 6 (0.8) | 6 (1.1) |
Diabetes controlled with insulin or equivalent | 75 (7.9) | 75 (9.8) | 55 (9.7) |
Diabetes with end organ damage | 32 (3.4) | 34 (4.4) | 30 (5.3) |
 Damage to the retina | 9 (0.9) | 8 (1.0) | 8 (1.4) |
 Nerve damage | 4 (0.4) | 4 (0.5) | 6 (1.1) |
 Kidney damage | 5 (0.5) | 9 (1.2) | 9 (1.6) |
 Brittle diabetes | 0 (0) | 0 (0) | 1 (0.2) |
Moderate or severe chronic kidney disease | 15 (1.6) | 18 (2.3) | 18 (3.2) |
Hemiplegia | 1 (0.1) | 0 (0) | 1 (0.2) |
Cancer within the last five years | 112 (11.7) | 118 (15.4) | 101 (17.8) |
 Breast cancer | 14 (1.5) | 17 (2.2) | 16 (2.8) |
 Colon cancer | 5 (0.5) | 3 (0.4) | 4 (0.7) |
 Prostate cancer | 14 (1.5) | 19 (2.5) | 16 (2.8) |
 Lung cancer | 1 (0.1) | 1 (0.1) | 2 (0.4) |
 Skin cancer | 22 (2.3) | 30 (3.9) | 27 (4.8) |
 Blood cancer/lymphoma | 4 (0.4) | 7 (0.9) | 9 (1.6) |
 Acute or chronic leukemia | 3 (0.3) | 6 (0.8) | 6 (1.1) |
Cancer within the past five years that has metastasized | 42 (4.4) | 36 (4.7) | 26 (4.6) |
Mild liver disease | 4 (0.4) | 5 (0.7) | 5 (0.9) |
 Hepatitis B | 1 (0.1) | 1 (0.1) | 1 (0.2) |
 Hepatitis C | 0 (0) | 1 (0.1) | 1 (0.2) |
 Cirrhosis | 1 (0.1) | 1 (0.1) | 0 (0) |
Liver disease (moderate to severe) | 6 (0.6) | 5 (0.7) | 2 (0.4) |
 Chronic jaundice | 2 (0.2) | 2 (0.3) | 1 (0.2) |
 Liver failure | 1 (0.1) | 1 (0.1) | 0 (0) |
 Liver transplant | 0 (0) | 0 (0) | 0 (0) |
AIDS or HIV | 0 (0) | 0 (0) | 0 (0) |
Taking warfarin | 69 (7.2) | 55 (7.2) | 44 (7.7) |